Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 18:35:33 UTC
Update Date2021-09-26 23:14:01 UTC
HMDB IDHMDB0257574
Secondary Accession NumbersNone
Metabolite Identification
Common Name4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide
Description4-[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanimidic acid belongs to the class of organic compounds known as 5'-deoxyribonucleosides. These are nucleosides in which the oxygen atom at the 5'position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives. Based on a literature review very few articles have been published on 4-[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-[(2r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
4-[5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanimidateGenerator
Chemical FormulaC13H18N6O4
Average Molecular Weight322.325
Monoisotopic Molecular Weight322.138953084
IUPAC Name4-[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide
Traditional Name4-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide
CAS Registry NumberNot Available
SMILES
NC(=O)CCCC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N
InChI Identifier
InChI=1S/C13H18N6O4/c14-7(20)3-1-2-6-9(21)10(22)13(23-6)19-5-18-8-11(15)16-4-17-12(8)19/h4-6,9-10,13,21-22H,1-3H2,(H2,14,20)(H2,15,16,17)
InChI KeyGECUAPJGZGRXSE-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 5'-deoxyribonucleosides. These are nucleosides in which the oxygen atom at the 5'position of the ribose moiety has been replaced by another atom. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives.
KingdomOrganic compounds
Super ClassNucleosides, nucleotides, and analogues
Class5'-deoxyribonucleosides
Sub ClassNot Available
Direct Parent5'-deoxyribonucleosides
Alternative Parents
Substituents
  • 5'-deoxyribonucleoside
  • N-glycosyl compound
  • Glycosyl compound
  • Pentose monosaccharide
  • 6-aminopurine
  • Purine
  • Imidazopyrimidine
  • Aminopyrimidine
  • Fatty acyl
  • Imidolactam
  • Pyrimidine
  • N-substituted imidazole
  • Monosaccharide
  • Fatty amide
  • Heteroaromatic compound
  • Tetrahydrofuran
  • Imidazole
  • Azole
  • Secondary alcohol
  • Primary carboxylic acid amide
  • Carboxamide group
  • Amino acid or derivatives
  • 1,2-diol
  • Oxacycle
  • Azacycle
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Amine
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-0.88ALOGPS
logP-1.8ChemAxon
logS-1.7ALOGPS
pKa (Strongest Acidic)12.48ChemAxon
pKa (Strongest Basic)3.92ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area162.4 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity78.87 m³·mol⁻¹ChemAxon
Polarizability32.09 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+163.37230932474
DeepCCS[M-H]-161.01430932474
DeepCCS[M-2H]-194.63130932474
DeepCCS[M+Na]+170.74230932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamideNC(=O)CCCC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N3716.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamideNC(=O)CCCC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N2385.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamideNC(=O)CCCC1OC(C(O)C1O)N1C=NC2=C1N=CN=C2N3297.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3119.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3018.3Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C4749.4Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #10C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O3200.7Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #10C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O3278.6Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #10C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O4720.9Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #2C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C)C1O[Si](C)(C)C3163.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #2C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C)C1O[Si](C)(C)C2954.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #2C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C)C1O[Si](C)(C)C4907.3Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #3C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O3189.8Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #3C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O3121.0Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #3C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O4911.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #4C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N)N=CN=C213213.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #4C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N)N=CN=C213186.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #4C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N)N=CN=C214947.4Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #5C[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C213180.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #5C[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C213128.3Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #5C[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C214822.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #6C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C3191.3Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #6C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C3118.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #6C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C4879.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #7C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O3206.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #7C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O3178.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #7C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O4925.9Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #8C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O3186.3Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #8C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O3120.9Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #8C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O4798.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #9C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O3276.5Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #9C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O3293.3Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TMS,isomer #9C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O5030.3Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3151.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3069.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #1C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C4380.5Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #2C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C3180.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #2C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C3151.6Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #2C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C4569.9Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #3C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C3151.3Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #3C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C3077.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #3C[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C4398.5Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #4C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O[Si](C)(C)C3252.9Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #4C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O[Si](C)(C)C3236.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #4C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C1O[Si](C)(C)C4593.0Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #5C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O3171.0Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #5C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O3223.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #5C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O4267.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #6C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O3241.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #6C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O3232.8Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #6C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O4561.4Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #7C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C3162.2Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #7C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C3218.6Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #7C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C4233.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #8C[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C3275.8Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #8C[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C3394.4Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TMS,isomer #8C[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C4389.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #1C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C3226.1Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #1C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C3194.4Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #1C[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C4143.5Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #2C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3137.3Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #2C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3139.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #2C[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C(O[Si](C)(C)C)C1O[Si](C)(C)C3812.3Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #3C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C213262.9Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #3C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C213323.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #3C[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C214023.8Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #4C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O3253.9Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #4C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O3312.9Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TMS,isomer #4C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O3992.8Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,6TMS,isomer #1C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C3266.1Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,6TMS,isomer #1C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C3227.5Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,6TMS,isomer #1C[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C32)C1O[Si](C)(C)C3641.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3723.7Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3655.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4703.7Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #10CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O3771.2Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #10CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O3872.5Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #10CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O4567.2Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3774.2Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3620.9Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(N)=O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4845.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O3769.8Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O3758.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O4792.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N)N=CN=C213791.5Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N)N=CN=C213788.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N)N=CN=C214826.2Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C213776.1Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C213760.5Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(N)=O)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C214694.3Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C3760.4Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C3756.2Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C4763.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O3789.4Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O3785.3Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O4806.3Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #8CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O3770.2Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #8CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O3757.9Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #8CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O4673.5Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #9CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O3850.3Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #9CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O3891.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,3TBDMS,isomer #9CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O4852.0Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3882.7Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3857.5Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4434.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C(C)(C)C3932.9Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C(C)(C)C3894.6Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N)N=CN=C32)C1O[Si](C)(C)C(C)(C)C4558.2Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O[Si](C)(C)C(C)(C)C3893.6Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O[Si](C)(C)C(C)(C)C3873.4Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CCCC(N)=O)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O[Si](C)(C)C(C)(C)C4426.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C3964.8Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C4006.4Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C4559.9Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #5CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O3870.0Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #5CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O3999.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #5CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O4295.6Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O3956.7Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O4004.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #6CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O4533.5Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C3854.5Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C3995.3Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #7CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O[Si](C)(C)C(C)(C)C4269.2Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #8CC(C)(C)[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C(C)(C)C4038.7Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #8CC(C)(C)[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C(C)(C)C4122.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,4TBDMS,isomer #8CC(C)(C)[Si](C)(C)N(C(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O)C1O)[Si](C)(C)C(C)(C)C4353.9Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4086.0Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4102.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N=CN2C1OC(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4348.8Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3982.4Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4079.1Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CCCC1OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C4081.1Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C214094.4Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C214226.5Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(O)C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC1N1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C214181.0Standard polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O4089.1Semi standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O4220.7Standard non polar33892256
4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(CCCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(N2C=NC3=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C32)C1O4155.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (Non-derivatized) - 70eV, Positivesplash10-056r-5921000000-0a0d605e6038093fdddd2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_7) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TMS_2_8) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-[(2R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]butanamide GC-MS (TBDMS_2_7) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound76504417
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]